 | • レポートコード：MRC2Q12-16795 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、117ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医療 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| コロナ禍により、医療機器用細胞毒性試験の世界市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に医療機器用細胞毒性試験のグローバル市場のxxx％を占める「溶出試験法」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「ディスポーザブル機器」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 医療機器用細胞毒性試験の中国市場規模は2021年にUS$xxxと分析されており、アメリカとヨーロッパの市場規模はそれぞれUS$xxxとUS$xxxです。アメリカの割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの医療機器用細胞毒性試験市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 医療機器用細胞毒性試験のグローバル主要プレイヤーには、Sartorius、UL、Eurofins、SGS、Emery Pharma、Nelson Labs、UFAG Laboratorien AG、Pacific BioLabs、NorthEast BioLab、Biosafe Ltd、Creative Bioarray、Evercyte、IONTOX、Applied StemCell、Xenometrix AG、TÜV SÜD、Medicilon、Huatongweiなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 医療機器用細胞毒性試験市場は、種類と用途によって区分されます。世界の医療機器用細胞毒性試験市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 溶出試験法、寒天重層法、直接接触法、MTTアッセイ法、その他 【用途別セグメント】 ディスポーザブル機器、インプラント、診断監視装置、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 医療機器用細胞毒性試験製品概要 - 種類別市場（溶出試験法、寒天重層法、直接接触法、MTTアッセイ法、その他） - 用途別市場（ディスポーザブル機器、インプラント、診断監視装置、その他） - 調査の目的 ・エグゼクティブサマリー - 世界の医療機器用細胞毒性試験販売量予測2017-2028 - 世界の医療機器用細胞毒性試験売上予測2017-2028 - 医療機器用細胞毒性試験の地域別販売量 - 医療機器用細胞毒性試験の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別医療機器用細胞毒性試験販売量 - 主要メーカー別医療機器用細胞毒性試験売上 - 主要メーカー別医療機器用細胞毒性試験価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（溶出試験法、寒天重層法、直接接触法、MTTアッセイ法、その他） - 医療機器用細胞毒性試験の種類別販売量 - 医療機器用細胞毒性試験の種類別売上 - 医療機器用細胞毒性試験の種類別価格 ・用途別市場規模（ディスポーザブル機器、インプラント、診断監視装置、その他） - 医療機器用細胞毒性試験の用途別販売量 - 医療機器用細胞毒性試験の用途別売上 - 医療機器用細胞毒性試験の用途別価格 ・北米市場 - 北米の医療機器用細胞毒性試験市場規模（種類別、用途別） - 主要国別の医療機器用細胞毒性試験市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの医療機器用細胞毒性試験市場規模（種類別、用途別） - 主要国別の医療機器用細胞毒性試験市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の医療機器用細胞毒性試験市場規模（種類別、用途別） - 主要国別の医療機器用細胞毒性試験市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の医療機器用細胞毒性試験市場規模（種類別、用途別） - 主要国別の医療機器用細胞毒性試験市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの医療機器用細胞毒性試験市場規模（種類別、用途別） - 主要国別の医療機器用細胞毒性試験市場規模（トルコ、サウジアラビア） ・企業情報 Sartorius、UL、Eurofins、SGS、Emery Pharma、Nelson Labs、UFAG Laboratorien AG、Pacific BioLabs、NorthEast BioLab、Biosafe Ltd、Creative Bioarray、Evercyte、IONTOX、Applied StemCell、Xenometrix AG、TÜV SÜD、Medicilon、Huatongwei ・産業チェーン及び販売チャネル分析 - 医療機器用細胞毒性試験の産業チェーン分析 - 医療機器用細胞毒性試験の原材料 - 医療機器用細胞毒性試験の生産プロセス - 医療機器用細胞毒性試験の販売及びマーケティング - 医療機器用細胞毒性試験の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 医療機器用細胞毒性試験の産業動向 - 医療機器用細胞毒性試験のマーケットドライバー - 医療機器用細胞毒性試験の課題 - 医療機器用細胞毒性試験の阻害要因 ・主な調査結果 |
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Medical Device Cytotoxicity Testing estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Medical Device Cytotoxicity Testing is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Medical Device Cytotoxicity Testing is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Medical Device Cytotoxicity Testing is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key companies of Medical Device Cytotoxicity Testing include Sartorius, UL, Eurofins, SGS, Emery Pharma, Nelson Labs, UFAG Laboratorien AG, Pacific BioLabs and NorthEast BioLab, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, revenue and gross margin. Major players’ headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Medical Device Cytotoxicity Testing companies, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Medical Device Cytotoxicity Testing market. Further, it explains the major drivers and regional dynamics of the global Medical Device Cytotoxicity Testing market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable revenue, market share and rank data of the companies for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Sartorius
UL
Eurofins
SGS
Emery Pharma
Nelson Labs
UFAG Laboratorien AG
Pacific BioLabs
NorthEast BioLab
Biosafe Ltd
Creative Bioarray
Evercyte
IONTOX
Applied StemCell
Xenometrix AG
TÜV SÜD
Medicilon
Huatongwei
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides revenue forecast data by type and by application segments based on value for the period 2017-2028.
Medical Device Cytotoxicity Testing Segment by Type
Elution Testing Method
Agar Overlay Method
Direct Contact Method
MTT Assay Method
Others
Medical Device Cytotoxicity Testing Segment by Application
Disposable Instruments
Implants
Diagnostic Monitoring Equipment
Others
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Medical Device Cytotoxicity Testing market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Medical Device Cytotoxicity Testing market size. Analyses of the global market trends, with historic market revenue data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Medical Device Cytotoxicity Testing, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Medical Device Cytotoxicity Testing, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Medical Device Cytotoxicity Testing revenue, market share and industry ranking of main companies, data from 2017 to 2022. Identification of the major stakeholders in the global Medical Device Cytotoxicity Testing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2017 to 2028. Evaluation and forecast the market size for Medical Device Cytotoxicity Testing revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Sartorius, UL, Eurofins, SGS, Emery Pharma, Nelson Labs, UFAG Laboratorien AG, Pacific BioLabs and NorthEast BioLab, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Medical Device Cytotoxicity Testing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Medical Device Cytotoxicity Testing companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: Asia Pacific by type, by application and by country/region, revenue for each segment.
Chapter 9: Latin America by type, by application and by country, revenue for each segment.
Chapter 10: Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Medical Device Cytotoxicity Testing revenue, gross margin, and recent development, etc.
Chapter 12: Analyst’s Viewpoints/Conclusions
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Medical Device Cytotoxicity Testing Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Elution Testing Method
1.2.3 Agar Overlay Method
1.2.4 Direct Contact Method
1.2.5 MTT Assay Method
1.2.6 Others
1.3 Market by Application
1.3.1 Global Medical Device Cytotoxicity Testing Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Disposable Instruments
1.3.3 Implants
1.3.4 Diagnostic Monitoring Equipment
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Medical Device Cytotoxicity Testing Market Perspective (2017-2028)
2.2 Medical Device Cytotoxicity Testing Growth Trends by Region
2.2.1 Medical Device Cytotoxicity Testing Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Medical Device Cytotoxicity Testing Historic Market Size by Region (2017-2022)
2.2.3 Medical Device Cytotoxicity Testing Forecasted Market Size by Region (2023-2028)
2.3 Medical Device Cytotoxicity Testing Market Dynamics
2.3.1 Medical Device Cytotoxicity Testing Industry Trends
2.3.2 Medical Device Cytotoxicity Testing Market Drivers
2.3.3 Medical Device Cytotoxicity Testing Market Challenges
2.3.4 Medical Device Cytotoxicity Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Medical Device Cytotoxicity Testing Players by Revenue
3.1.1 Global Top Medical Device Cytotoxicity Testing Players by Revenue (2017-2022)
3.1.2 Global Medical Device Cytotoxicity Testing Revenue Market Share by Players (2017-2022)
3.2 Global Medical Device Cytotoxicity Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Medical Device Cytotoxicity Testing Revenue
3.4 Global Medical Device Cytotoxicity Testing Market Concentration Ratio
3.4.1 Global Medical Device Cytotoxicity Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Medical Device Cytotoxicity Testing Revenue in 2021
3.5 Medical Device Cytotoxicity Testing Key Players Head office and Area Served
3.6 Key Players Medical Device Cytotoxicity Testing Product Solution and Service
3.7 Date of Enter into Medical Device Cytotoxicity Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Medical Device Cytotoxicity Testing Breakdown Data by Type
4.1 Global Medical Device Cytotoxicity Testing Historic Market Size by Type (2017-2022)
4.2 Global Medical Device Cytotoxicity Testing Forecasted Market Size by Type (2023-2028)
5 Medical Device Cytotoxicity Testing Breakdown Data by Application
5.1 Global Medical Device Cytotoxicity Testing Historic Market Size by Application (2017-2022)
5.2 Global Medical Device Cytotoxicity Testing Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Medical Device Cytotoxicity Testing Market Size (2017-2028)
6.2 North America Medical Device Cytotoxicity Testing Market Size by Type
6.2.1 North America Medical Device Cytotoxicity Testing Market Size by Type (2017-2022)
6.2.2 North America Medical Device Cytotoxicity Testing Market Size by Type (2023-2028)
6.2.3 North America Medical Device Cytotoxicity Testing Market Share by Type (2017-2028)
6.3 North America Medical Device Cytotoxicity Testing Market Size by Application
6.3.1 North America Medical Device Cytotoxicity Testing Market Size by Application (2017-2022)
6.3.2 North America Medical Device Cytotoxicity Testing Market Size by Application (2023-2028)
6.3.3 North America Medical Device Cytotoxicity Testing Market Share by Application (2017-2028)
6.4 North America Medical Device Cytotoxicity Testing Market Size by Country
6.4.1 North America Medical Device Cytotoxicity Testing Market Size by Country (2017-2022)
6.4.2 North America Medical Device Cytotoxicity Testing Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Medical Device Cytotoxicity Testing Market Size (2017-2028)
7.2 Europe Medical Device Cytotoxicity Testing Market Size by Type
7.2.1 Europe Medical Device Cytotoxicity Testing Market Size by Type (2017-2022)
7.2.2 Europe Medical Device Cytotoxicity Testing Market Size by Type (2023-2028)
7.2.3 Europe Medical Device Cytotoxicity Testing Market Share by Type (2017-2028)
7.3 Europe Medical Device Cytotoxicity Testing Market Size by Application
7.3.1 Europe Medical Device Cytotoxicity Testing Market Size by Application (2017-2022)
7.3.2 Europe Medical Device Cytotoxicity Testing Market Size by Application (2023-2028)
7.3.3 Europe Medical Device Cytotoxicity Testing Market Share by Application (2017-2028)
7.4 Europe Medical Device Cytotoxicity Testing Market Size by Country
7.4.1 Europe Medical Device Cytotoxicity Testing Market Size by Country (2017-2022)
7.4.2 Europe Medical Device Cytotoxicity Testing Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Medical Device Cytotoxicity Testing Market Size (2017-2028)
8.2 Asia-Pacific Medical Device Cytotoxicity Testing Market Size by Type
8.2.1 Asia-Pacific Medical Device Cytotoxicity Testing Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Medical Device Cytotoxicity Testing Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Medical Device Cytotoxicity Testing Market Share by Type (2017-2028)
8.3 Asia-Pacific Medical Device Cytotoxicity Testing Market Size by Application
8.3.1 Asia-Pacific Medical Device Cytotoxicity Testing Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Medical Device Cytotoxicity Testing Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Medical Device Cytotoxicity Testing Market Share by Application (2017-2028)
8.4 Asia-Pacific Medical Device Cytotoxicity Testing Market Size by Region
8.4.1 Asia-Pacific Medical Device Cytotoxicity Testing Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Medical Device Cytotoxicity Testing Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Medical Device Cytotoxicity Testing Market Size (2017-2028)
9.2 Latin America Medical Device Cytotoxicity Testing Market Size by Type
9.2.1 Latin America Medical Device Cytotoxicity Testing Market Size by Type (2017-2022)
9.2.2 Latin America Medical Device Cytotoxicity Testing Market Size by Type (2023-2028)
9.2.3 Latin America Medical Device Cytotoxicity Testing Market Share by Type (2017-2028)
9.3 Latin America Medical Device Cytotoxicity Testing Market Size by Application
9.3.1 Latin America Medical Device Cytotoxicity Testing Market Size by Application (2017-2022)
9.3.2 Latin America Medical Device Cytotoxicity Testing Market Size by Application (2023-2028)
9.3.3 Latin America Medical Device Cytotoxicity Testing Market Share by Application (2017-2028)
9.4 Latin America Medical Device Cytotoxicity Testing Market Size by Country
9.4.1 Latin America Medical Device Cytotoxicity Testing Market Size by Country (2017-2022)
9.4.2 Latin America Medical Device Cytotoxicity Testing Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Medical Device Cytotoxicity Testing Market Size (2017-2028)
10.2 Middle East & Africa Medical Device Cytotoxicity Testing Market Size by Type
10.2.1 Middle East & Africa Medical Device Cytotoxicity Testing Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Medical Device Cytotoxicity Testing Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Medical Device Cytotoxicity Testing Market Share by Type (2017-2028)
10.3 Middle East & Africa Medical Device Cytotoxicity Testing Market Size by Application
10.3.1 Middle East & Africa Medical Device Cytotoxicity Testing Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Medical Device Cytotoxicity Testing Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Medical Device Cytotoxicity Testing Market Share by Application (2017-2028)
10.4 Middle East & Africa Medical Device Cytotoxicity Testing Market Size by Country
10.4.1 Middle East & Africa Medical Device Cytotoxicity Testing Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Medical Device Cytotoxicity Testing Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Sartorius
11.1.1 Sartorius Company Details
11.1.2 Sartorius Business Overview
11.1.3 Sartorius Medical Device Cytotoxicity Testing Introduction
11.1.4 Sartorius Revenue in Medical Device Cytotoxicity Testing Business (2017-2022)
11.1.5 Sartorius Recent Developments
11.2 UL
11.2.1 UL Company Details
11.2.2 UL Business Overview
11.2.3 UL Medical Device Cytotoxicity Testing Introduction
11.2.4 UL Revenue in Medical Device Cytotoxicity Testing Business (2017-2022)
11.2.5 UL Recent Developments
11.3 Eurofins
11.3.1 Eurofins Company Details
11.3.2 Eurofins Business Overview
11.3.3 Eurofins Medical Device Cytotoxicity Testing Introduction
11.3.4 Eurofins Revenue in Medical Device Cytotoxicity Testing Business (2017-2022)
11.3.5 Eurofins Recent Developments
11.4 SGS
11.4.1 SGS Company Details
11.4.2 SGS Business Overview
11.4.3 SGS Medical Device Cytotoxicity Testing Introduction
11.4.4 SGS Revenue in Medical Device Cytotoxicity Testing Business (2017-2022)
11.4.5 SGS Recent Developments
11.5 Emery Pharma
11.5.1 Emery Pharma Company Details
11.5.2 Emery Pharma Business Overview
11.5.3 Emery Pharma Medical Device Cytotoxicity Testing Introduction
11.5.4 Emery Pharma Revenue in Medical Device Cytotoxicity Testing Business (2017-2022)
11.5.5 Emery Pharma Recent Developments
11.6 Nelson Labs
11.6.1 Nelson Labs Company Details
11.6.2 Nelson Labs Business Overview
11.6.3 Nelson Labs Medical Device Cytotoxicity Testing Introduction
11.6.4 Nelson Labs Revenue in Medical Device Cytotoxicity Testing Business (2017-2022)
11.6.5 Nelson Labs Recent Developments
11.7 UFAG Laboratorien AG
11.7.1 UFAG Laboratorien AG Company Details
11.7.2 UFAG Laboratorien AG Business Overview
11.7.3 UFAG Laboratorien AG Medical Device Cytotoxicity Testing Introduction
11.7.4 UFAG Laboratorien AG Revenue in Medical Device Cytotoxicity Testing Business (2017-2022)
11.7.5 UFAG Laboratorien AG Recent Developments
11.8 Pacific BioLabs
11.8.1 Pacific BioLabs Company Details
11.8.2 Pacific BioLabs Business Overview
11.8.3 Pacific BioLabs Medical Device Cytotoxicity Testing Introduction
11.8.4 Pacific BioLabs Revenue in Medical Device Cytotoxicity Testing Business (2017-2022)
11.8.5 Pacific BioLabs Recent Developments
11.9 NorthEast BioLab
11.9.1 NorthEast BioLab Company Details
11.9.2 NorthEast BioLab Business Overview
11.9.3 NorthEast BioLab Medical Device Cytotoxicity Testing Introduction
11.9.4 NorthEast BioLab Revenue in Medical Device Cytotoxicity Testing Business (2017-2022)
11.9.5 NorthEast BioLab Recent Developments
11.10 Biosafe Ltd
11.10.1 Biosafe Ltd Company Details
11.10.2 Biosafe Ltd Business Overview
11.10.3 Biosafe Ltd Medical Device Cytotoxicity Testing Introduction
11.10.4 Biosafe Ltd Revenue in Medical Device Cytotoxicity Testing Business (2017-2022)
11.10.5 Biosafe Ltd Recent Developments
11.11 Creative Bioarray
11.11.1 Creative Bioarray Company Details
11.11.2 Creative Bioarray Business Overview
11.11.3 Creative Bioarray Medical Device Cytotoxicity Testing Introduction
11.11.4 Creative Bioarray Revenue in Medical Device Cytotoxicity Testing Business (2017-2022)
11.11.5 Creative Bioarray Recent Developments
11.12 Evercyte
11.12.1 Evercyte Company Details
11.12.2 Evercyte Business Overview
11.12.3 Evercyte Medical Device Cytotoxicity Testing Introduction
11.12.4 Evercyte Revenue in Medical Device Cytotoxicity Testing Business (2017-2022)
11.12.5 Evercyte Recent Developments
11.13 IONTOX
11.13.1 IONTOX Company Details
11.13.2 IONTOX Business Overview
11.13.3 IONTOX Medical Device Cytotoxicity Testing Introduction
11.13.4 IONTOX Revenue in Medical Device Cytotoxicity Testing Business (2017-2022)
11.13.5 IONTOX Recent Developments
11.14 Applied StemCell
11.14.1 Applied StemCell Company Details
11.14.2 Applied StemCell Business Overview
11.14.3 Applied StemCell Medical Device Cytotoxicity Testing Introduction
11.14.4 Applied StemCell Revenue in Medical Device Cytotoxicity Testing Business (2017-2022)
11.14.5 Applied StemCell Recent Developments
11.15 Xenometrix AG
11.15.1 Xenometrix AG Company Details
11.15.2 Xenometrix AG Business Overview
11.15.3 Xenometrix AG Medical Device Cytotoxicity Testing Introduction
11.15.4 Xenometrix AG Revenue in Medical Device Cytotoxicity Testing Business (2017-2022)
11.15.5 Xenometrix AG Recent Developments
11.16 TÜV SÜD
11.16.1 TÜV SÜD Company Details
11.16.2 TÜV SÜD Business Overview
11.16.3 TÜV SÜD Medical Device Cytotoxicity Testing Introduction
11.16.4 TÜV SÜD Revenue in Medical Device Cytotoxicity Testing Business (2017-2022)
11.16.5 TÜV SÜD Recent Developments
11.17 Medicilon
11.17.1 Medicilon Company Details
11.17.2 Medicilon Business Overview
11.17.3 Medicilon Medical Device Cytotoxicity Testing Introduction
11.17.4 Medicilon Revenue in Medical Device Cytotoxicity Testing Business (2017-2022)
11.17.5 Medicilon Recent Developments
11.18 Huatongwei
11.18.1 Huatongwei Company Details
11.18.2 Huatongwei Business Overview
11.18.3 Huatongwei Medical Device Cytotoxicity Testing Introduction
11.18.4 Huatongwei Revenue in Medical Device Cytotoxicity Testing Business (2017-2022)
11.18.5 Huatongwei Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
Table 1. Global Medical Device Cytotoxicity Testing Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Elution Testing Method
Table 3. Key Players of Agar Overlay Method
Table 4. Key Players of Direct Contact Method
Table 5. Key Players of MTT Assay Method
Table 6. Key Players of Others
Table 7. Global Medical Device Cytotoxicity Testing Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 8. Global Medical Device Cytotoxicity Testing Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 9. Global Medical Device Cytotoxicity Testing Market Size by Region (2017-2022) & (US$ Million)
Table 10. Global Medical Device Cytotoxicity Testing Market Share by Region (2017-2022)
Table 11. Global Medical Device Cytotoxicity Testing Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 12. Global Medical Device Cytotoxicity Testing Market Share by Region (2023-2028)
Table 13. Medical Device Cytotoxicity Testing Market Trends
Table 14. Medical Device Cytotoxicity Testing Market Drivers
Table 15. Medical Device Cytotoxicity Testing Market Challenges
Table 16. Medical Device Cytotoxicity Testing Market Restraints
Table 17. Global Medical Device Cytotoxicity Testing Revenue by Players (2017-2022) & (US$ Million)
Table 18. Global Medical Device Cytotoxicity Testing Revenue Share by Players (2017-2022)
Table 19. Global Top Medical Device Cytotoxicity Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Medical Device Cytotoxicity Testing as of 2021)
Table 20. Ranking of Global Top Medical Device Cytotoxicity Testing Companies by Revenue (US$ Million) in 2021
Table 21. Global 5 Largest Players Market Share by Medical Device Cytotoxicity Testing Revenue (CR5 and HHI) & (2017-2022)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Medical Device Cytotoxicity Testing Product Solution and Service
Table 24. Date of Enter into Medical Device Cytotoxicity Testing Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Medical Device Cytotoxicity Testing Market Size by Type (2017-2022) & (US$ Million)
Table 27. Global Medical Device Cytotoxicity Testing Revenue Market Share by Type (2017-2022)
Table 28. Global Medical Device Cytotoxicity Testing Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 29. Global Medical Device Cytotoxicity Testing Revenue Market Share by Type (2023-2028)
Table 30. Global Medical Device Cytotoxicity Testing Market Size by Application (2017-2022) & (US$ Million)
Table 31. Global Medical Device Cytotoxicity Testing Revenue Share by Application (2017-2022)
Table 32. Global Medical Device Cytotoxicity Testing Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 33. Global Medical Device Cytotoxicity Testing Revenue Share by Application (2023-2028)
Table 34. North America Medical Device Cytotoxicity Testing Market Size by Type (2017-2022) & (US$ Million)
Table 35. North America Medical Device Cytotoxicity Testing Market Size by Type (2023-2028) & (US$ Million)
Table 36. North America Medical Device Cytotoxicity Testing Market Size by Application (2017-2022) & (US$ Million)
Table 37. North America Medical Device Cytotoxicity Testing Market Size by Application (2023-2028) & (US$ Million)
Table 38. North America Medical Device Cytotoxicity Testing Market Size by Country (2017-2022) & (US$ Million)
Table 39. North America Medical Device Cytotoxicity Testing Market Size by Country (2023-2028) & (US$ Million)
Table 40. Europe Medical Device Cytotoxicity Testing Market Size by Type (2017-2022) & (US$ Million)
Table 41. Europe Medical Device Cytotoxicity Testing Market Size by Type (2023-2028) & (US$ Million)
Table 42. Europe Medical Device Cytotoxicity Testing Market Size by Application (2017-2022) & (US$ Million)
Table 43. Europe Medical Device Cytotoxicity Testing Market Size by Application (2023-2028) & (US$ Million)
Table 44. Europe Medical Device Cytotoxicity Testing Market Size by Country (2017-2022) & (US$ Million)
Table 45. Europe Medical Device Cytotoxicity Testing Market Size by Country (2023-2028) & (US$ Million)
Table 46. Asia Pacific Medical Device Cytotoxicity Testing Market Size by Type (2017-2022) & (US$ Million)
Table 47. Asia Pacific Medical Device Cytotoxicity Testing Market Size by Type (2023-2028) & (US$ Million)
Table 48. Asia Pacific Medical Device Cytotoxicity Testing Market Size by Application (2017-2022) & (US$ Million)
Table 49. Asia Pacific Medical Device Cytotoxicity Testing Market Size by Application (2023-2028) & (US$ Million)
Table 50. Asia Pacific Medical Device Cytotoxicity Testing Market Size by Region (2017-2022) & (US$ Million)
Table 51. Asia Pacific Medical Device Cytotoxicity Testing Market Size by Region (2023-2028) & (US$ Million)
Table 52. Latin America Medical Device Cytotoxicity Testing Market Size by Type (2017-2022) & (US$ Million)
Table 53. Latin America Medical Device Cytotoxicity Testing Market Size by Type (2023-2028) & (US$ Million)
Table 54. Latin America Medical Device Cytotoxicity Testing Market Size by Application (2017-2022) & (US$ Million)
Table 55. Latin America Medical Device Cytotoxicity Testing Market Size by Application (2023-2028) & (US$ Million)
Table 56. Latin America Medical Device Cytotoxicity Testing Market Size by Country (2017-2022) & (US$ Million)
Table 57. Latin America Medical Device Cytotoxicity Testing Market Size by Country (2023-2028) & (US$ Million)
Table 58. Middle East and Africa Medical Device Cytotoxicity Testing Market Size by Type (2017-2022) & (US$ Million)
Table 59. Middle East and Africa Medical Device Cytotoxicity Testing Market Size by Type (2023-2028) & (US$ Million)
Table 60. Middle East and Africa Medical Device Cytotoxicity Testing Market Size by Application (2017-2022) & (US$ Million)
Table 61. Middle East and Africa Medical Device Cytotoxicity Testing Market Size by Application (2023-2028) & (US$ Million)
Table 62. Middle East and Africa Medical Device Cytotoxicity Testing Market Size by Country (2017-2022) & (US$ Million)
Table 63. Middle East and Africa Medical Device Cytotoxicity Testing Market Size by Country (2023-2028) & (US$ Million)
Table 64. Sartorius Company Details
Table 65. Sartorius Business Overview
Table 66. Sartorius Medical Device Cytotoxicity Testing Product
Table 67. Sartorius Revenue in Medical Device Cytotoxicity Testing Business (2017-2022) & (US$ Million)
Table 68. Sartorius Recent Developments
Table 69. UL Company Details
Table 70. UL Business Overview
Table 71. UL Medical Device Cytotoxicity Testing Product
Table 72. UL Revenue in Medical Device Cytotoxicity Testing Business (2017-2022) & (US$ Million)
Table 73. UL Recent Developments
Table 74. Eurofins Company Details
Table 75. Eurofins Business Overview
Table 76. Eurofins Medical Device Cytotoxicity Testing Product
Table 77. Eurofins Revenue in Medical Device Cytotoxicity Testing Business (2017-2022) & (US$ Million)
Table 78. Eurofins Recent Developments
Table 79. SGS Company Details
Table 80. SGS Business Overview
Table 81. SGS Medical Device Cytotoxicity Testing Product
Table 82. SGS Revenue in Medical Device Cytotoxicity Testing Business (2017-2022) & (US$ Million)
Table 83. SGS Recent Developments
Table 84. Emery Pharma Company Details
Table 85. Emery Pharma Business Overview
Table 86. Emery Pharma Medical Device Cytotoxicity Testing Product
Table 87. Emery Pharma Revenue in Medical Device Cytotoxicity Testing Business (2017-2022) & (US$ Million)
Table 88. Emery Pharma Recent Developments
Table 89. Nelson Labs Company Details
Table 90. Nelson Labs Business Overview
Table 91. Nelson Labs Medical Device Cytotoxicity Testing Product
Table 92. Nelson Labs Revenue in Medical Device Cytotoxicity Testing Business (2017-2022) & (US$ Million)
Table 93. Nelson Labs Recent Developments
Table 94. UFAG Laboratorien AG Company Details
Table 95. UFAG Laboratorien AG Business Overview
Table 96. UFAG Laboratorien AG Medical Device Cytotoxicity Testing Product
Table 97. UFAG Laboratorien AG Revenue in Medical Device Cytotoxicity Testing Business (2017-2022) & (US$ Million)
Table 98. UFAG Laboratorien AG Recent Developments
Table 99. Pacific BioLabs Company Details
Table 100. Pacific BioLabs Business Overview
Table 101. Pacific BioLabs Medical Device Cytotoxicity Testing Product
Table 102. Pacific BioLabs Revenue in Medical Device Cytotoxicity Testing Business (2017-2022) & (US$ Million)
Table 103. Pacific BioLabs Recent Developments
Table 104. NorthEast BioLab Company Details
Table 105. NorthEast BioLab Business Overview
Table 106. NorthEast BioLab Medical Device Cytotoxicity Testing Product
Table 107. NorthEast BioLab Revenue in Medical Device Cytotoxicity Testing Business (2017-2022) & (US$ Million)
Table 108. NorthEast BioLab Recent Developments
Table 109. Biosafe Ltd Company Details
Table 110. Biosafe Ltd Business Overview
Table 111. Biosafe Ltd Medical Device Cytotoxicity Testing Product
Table 112. Biosafe Ltd Revenue in Medical Device Cytotoxicity Testing Business (2017-2022) & (US$ Million)
Table 113. Biosafe Ltd Recent Developments
Table 114. Creative Bioarray Company Details
Table 115. Creative Bioarray Business Overview
Table 116. Creative Bioarray Medical Device Cytotoxicity Testing Product
Table 117. Creative Bioarray Revenue in Medical Device Cytotoxicity Testing Business (2017-2022) & (US$ Million)
Table 118. Creative Bioarray Recent Developments
Table 119. Evercyte Company Details
Table 120. Evercyte Business Overview
Table 121. Evercyte Medical Device Cytotoxicity Testing Product
Table 122. Evercyte Revenue in Medical Device Cytotoxicity Testing Business (2017-2022) & (US$ Million)
Table 123. Evercyte Recent Developments
Table 124. IONTOX Company Details
Table 125. IONTOX Business Overview
Table 126. IONTOX Medical Device Cytotoxicity Testing Product
Table 127. IONTOX Revenue in Medical Device Cytotoxicity Testing Business (2017-2022) & (US$ Million)
Table 128. IONTOX Recent Developments
Table 129. Applied StemCell Company Details
Table 130. Applied StemCell Business Overview
Table 131. Applied StemCell Medical Device Cytotoxicity Testing Product
Table 132. Applied StemCell Revenue in Medical Device Cytotoxicity Testing Business (2017-2022) & (US$ Million)
Table 133. Applied StemCell Recent Developments
Table 134. Xenometrix AG Company Details
Table 135. Xenometrix AG Business Overview
Table 136. Xenometrix AG Medical Device Cytotoxicity Testing Product
Table 137. Xenometrix AG Revenue in Medical Device Cytotoxicity Testing Business (2017-2022) & (US$ Million)
Table 138. Xenometrix AG Recent Developments
Table 139. TÜV SÜD Company Details
Table 140. TÜV SÜD Business Overview
Table 141. TÜV SÜD Medical Device Cytotoxicity Testing Product
Table 142. TÜV SÜD Revenue in Medical Device Cytotoxicity Testing Business (2017-2022) & (US$ Million)
Table 143. TÜV SÜD Recent Developments
Table 144. Medicilon Company Details
Table 145. Medicilon Business Overview
Table 146. Medicilon Medical Device Cytotoxicity Testing Product
Table 147. Medicilon Revenue in Medical Device Cytotoxicity Testing Business (2017-2022) & (US$ Million)
Table 148. Medicilon Recent Developments
Table 149. Huatongwei Company Details
Table 150. Huatongwei Business Overview
Table 151. Huatongwei Medical Device Cytotoxicity Testing Product
Table 152. Huatongwei Revenue in Medical Device Cytotoxicity Testing Business (2017-2022) & (US$ Million)
Table 153. Huatongwei Recent Developments
Table 154. Research Programs/Design for This Report
Table 155. Key Data Information from Secondary Sources
Table 156. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Medical Device Cytotoxicity Testing Market Share by Type: 2021 VS 2028
Figure 2. Elution Testing Method Features
Figure 3. Agar Overlay Method Features
Figure 4. Direct Contact Method Features
Figure 5. MTT Assay Method Features
Figure 6. Others Features
Figure 7. Global Medical Device Cytotoxicity Testing Market Share by Application: 2021 VS 2028
Figure 8. Disposable Instruments Case Studies
Figure 9. Implants Case Studies
Figure 10. Diagnostic Monitoring Equipment Case Studies
Figure 11. Others Case Studies
Figure 12. Medical Device Cytotoxicity Testing Report Years Considered
Figure 13. Global Medical Device Cytotoxicity Testing Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 14. Global Medical Device Cytotoxicity Testing Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 15. Global Medical Device Cytotoxicity Testing Market Share by Region: 2021 VS 2028
Figure 16. Global Medical Device Cytotoxicity Testing Market Share by Players in 2021
Figure 17. Global Top Medical Device Cytotoxicity Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Medical Device Cytotoxicity Testing as of 2021)
Figure 18. The Top 10 and 5 Players Market Share by Medical Device Cytotoxicity Testing Revenue in 2021
Figure 19. North America Medical Device Cytotoxicity Testing Market Size YoY (2017-2028) & (US$ Million)
Figure 20. North America Medical Device Cytotoxicity Testing Market Size Market Share by Type (2017-2028)
Figure 21. North America Medical Device Cytotoxicity Testing Market Size Market Share by Application (2017-2028)
Figure 22. North America Medical Device Cytotoxicity Testing Market Size Share by Country (2017-2028)
Figure 23. United States Medical Device Cytotoxicity Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Canada Medical Device Cytotoxicity Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Europe Medical Device Cytotoxicity Testing Market Size YoY (2017-2028) & (US$ Million)
Figure 26. Europe Medical Device Cytotoxicity Testing Market Size Market Share by Type (2017-2028)
Figure 27. Europe Medical Device Cytotoxicity Testing Market Size Market Share by Application (2017-2028)
Figure 28. Europe Medical Device Cytotoxicity Testing Market Size Share by Country (2017-2028)
Figure 29. Germany Medical Device Cytotoxicity Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. France Medical Device Cytotoxicity Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. U.K. Medical Device Cytotoxicity Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Italy Medical Device Cytotoxicity Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Russia Medical Device Cytotoxicity Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Nordic Countries Medical Device Cytotoxicity Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Asia-Pacific Medical Device Cytotoxicity Testing Market Size YoY (2017-2028) & (US$ Million)
Figure 36. Asia Pacific Medical Device Cytotoxicity Testing Market Size Market Share by Type (2017-2028)
Figure 37. Asia Pacific Medical Device Cytotoxicity Testing Market Size Market Share by Application (2017-2028)
Figure 38. Asia Pacific Medical Device Cytotoxicity Testing Market Size Share by Region (2017-2028)
Figure 39. China Medical Device Cytotoxicity Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Japan Medical Device Cytotoxicity Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. South Korea Medical Device Cytotoxicity Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Southeast Asia Medical Device Cytotoxicity Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. India Medical Device Cytotoxicity Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Australia Medical Device Cytotoxicity Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. Latin America Medical Device Cytotoxicity Testing Market Size YoY (2017-2028) & (US$ Million)
Figure 46. Latin America Medical Device Cytotoxicity Testing Market Size Market Share by Type (2017-2028)
Figure 47. Latin America Medical Device Cytotoxicity Testing Market Size Market Share by Application (2017-2028)
Figure 48. Latin America Medical Device Cytotoxicity Testing Market Size Share by Country (2017-2028)
Figure 49. Mexico Medical Device Cytotoxicity Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 50. Brazil Medical Device Cytotoxicity Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 51. Middle East & Africa Medical Device Cytotoxicity Testing Market Size YoY (2017-2028) & (US$ Million)
Figure 52. Middle East and Africa Medical Device Cytotoxicity Testing Market Size Market Share by Type (2017-2028)
Figure 53. Middle East and Africa Medical Device Cytotoxicity Testing Market Size Market Share by Application (2017-2028)
Figure 54. Middle East and Africa Medical Device Cytotoxicity Testing Market Size Share by Country (2017-2028)
Figure 55. Turkey Medical Device Cytotoxicity Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 56. Saudi Arabia Medical Device Cytotoxicity Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 57. UAE Medical Device Cytotoxicity Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 58. Sartorius Revenue Growth Rate in Medical Device Cytotoxicity Testing Business (2017-2022)
Figure 59. UL Revenue Growth Rate in Medical Device Cytotoxicity Testing Business (2017-2022)
Figure 60. Eurofins Revenue Growth Rate in Medical Device Cytotoxicity Testing Business (2017-2022)
Figure 61. SGS Revenue Growth Rate in Medical Device Cytotoxicity Testing Business (2017-2022)
Figure 62. Emery Pharma Revenue Growth Rate in Medical Device Cytotoxicity Testing Business (2017-2022)
Figure 63. Nelson Labs Revenue Growth Rate in Medical Device Cytotoxicity Testing Business (2017-2022)
Figure 64. UFAG Laboratorien AG Revenue Growth Rate in Medical Device Cytotoxicity Testing Business (2017-2022)
Figure 65. Pacific BioLabs Revenue Growth Rate in Medical Device Cytotoxicity Testing Business (2017-2022)
Figure 66. NorthEast BioLab Revenue Growth Rate in Medical Device Cytotoxicity Testing Business (2017-2022)
Figure 67. Biosafe Ltd Revenue Growth Rate in Medical Device Cytotoxicity Testing Business (2017-2022)
Figure 68. Creative Bioarray Revenue Growth Rate in Medical Device Cytotoxicity Testing Business (2017-2022)
Figure 69. Evercyte Revenue Growth Rate in Medical Device Cytotoxicity Testing Business (2017-2022)
Figure 70. IONTOX Revenue Growth Rate in Medical Device Cytotoxicity Testing Business (2017-2022)
Figure 71. Applied StemCell Revenue Growth Rate in Medical Device Cytotoxicity Testing Business (2017-2022)
Figure 72. Xenometrix AG Revenue Growth Rate in Medical Device Cytotoxicity Testing Business (2017-2022)
Figure 73. TÜV SÜD Revenue Growth Rate in Medical Device Cytotoxicity Testing Business (2017-2022)
Figure 74. Medicilon Revenue Growth Rate in Medical Device Cytotoxicity Testing Business (2017-2022)
Figure 75. Huatongwei Revenue Growth Rate in Medical Device Cytotoxicity Testing Business (2017-2022)
Figure 76. Bottom-up and Top-down Approaches for This Report
Figure 77. Data Triangulation
Figure 78. Key Executives Interviewed